Health Care Team, US Government Accountability Office (GOA)
Discussion focus on the top legal and regulatory issues affecting the delivery and reimbursement of telehealth services during the COVID-19 pandemic and how legislatures and government agencies at federal and state levels are responding in the aftermath to implement permanent changes and enforce fraudulent activities. The session provides valuable insights for startups and existing telemedicine practices seeking to understand strategic planning to optimize market success and maintain a compliant multi-state practice.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.